RGPX

Regenerex Pharma, Inc. is engaged in developing and marketing woundcare healing products. The Company has three technologies for different types of wound conditions; first is for closing chronic wounds; second is for accelerating closure of acute or surgical wounds, and third solves the issue on contamination of all types of wounds including the destruction of biofilms. The Company's product includes Xcellderma OTC, Accelerex Sterile Wound Cream, and Accelerex Impregnated Sterile Wound Dressing. Xcellderma OTC is a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds. Accelerex is a custom-designed, unit-dose, sterile wound dressing impregnated with an ointment containing QBx. Its Accelerex Impregnated Sterile Wound Dressing is used as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.